Based on the cell fusion theory and the assumption that macrophage–cancer cell fusion creates hybrids expressing phenotypic characteristics of macrophages, we used the macrophage-specific marker CD163 as a surrogate marker for detecting fusion events in a clinical tumor material. Here, CD163 is linked to cancer.